Broadcasting
Compare Stocks
4 / 10Stock Comparison
CURI vs DIS vs WBD vs FOXA
Revenue, margins, valuation, and 5-year total return — side by side.
Entertainment
Entertainment
Entertainment
CURI vs DIS vs WBD vs FOXA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Broadcasting | Entertainment | Entertainment | Entertainment |
| Market Cap | $181M | $187.52B | $67.97B | $14.10B |
| Revenue (TTM) | $72M | $97.26B | $37.22B | $16.58B |
| Net Income (TTM) | $-6M | $11.22B | $-2.15B | $1.89B |
| Gross Margin | 56.6% | 37.2% | 38.2% | 33.1% |
| Operating Margin | -10.2% | 15.5% | 4.5% | 19.0% |
| Forward P/E | 88.0x | 16.0x | 93.5x | 13.6x |
| Total Debt | $12M | $44.88B | $32.57B | $7.46B |
| Cash & Equiv. | $18M | $5.70B | $4.57B | $5.35B |
CURI vs DIS vs WBD vs FOXA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CuriosityStream Inc. (CURI) | 100 | 31.5 | -68.5% |
| The Walt Disney Com… (DIS) | 100 | 92.1 | -7.9% |
| Warner Bros. Discov… (WBD) | 100 | 124.6 | +24.6% |
| Fox Corporation (FOXA) | 100 | 215.8 | +115.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CURI vs DIS vs WBD vs FOXA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CURI is the #2 pick in this set and the best alternative if growth and dividends is your priority.
- 40.1% revenue growth vs WBD's -5.1%
- 12.4% yield, 2-year raise streak, vs FOXA's 1.0%, (1 stock pays no dividend)
DIS is the clearest fit if your priority is quality.
- 11.5% margin vs CURI's -9.0%
WBD is the clearest fit if your priority is momentum.
- +200.9% vs CURI's -21.7%
FOXA carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 3 yrs, beta 0.54, yield 1.0%
- Rev growth 16.6%, EPS growth 56.9%, 3Y rev CAGR 5.3%
- 31.1% 10Y total return vs DIS's 11.1%
- Lower volatility, beta 0.54, Low D/E 60.4%, current ratio 2.91x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 40.1% revenue growth vs WBD's -5.1% | |
| Value | Lower P/E (13.6x vs 93.5x) | |
| Quality / Margins | 11.5% margin vs CURI's -9.0% | |
| Stability / Safety | Beta 0.54 vs CURI's 1.30 | |
| Dividends | 12.4% yield, 2-year raise streak, vs FOXA's 1.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +200.9% vs CURI's -21.7% | |
| Efficiency (ROA) | 8.8% ROA vs CURI's -8.2%, ROIC 16.5% vs -12.2% |
CURI vs DIS vs WBD vs FOXA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CURI vs DIS vs WBD vs FOXA — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FOXA leads in 2 of 6 categories
CURI leads 1 • DIS leads 0 • WBD leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CURI leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DIS is the larger business by revenue, generating $97.3B annually — 1357.3x CURI's $72M. DIS is the more profitable business, keeping 11.5% of every revenue dollar as net income compared to CURI's -9.0%. On growth, CURI holds the edge at +35.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $72M | $97.3B | $37.2B | $16.6B |
| EBITDAEarnings before interest/tax | $14M | $20.5B | $10.7B | $3.5B |
| Net IncomeAfter-tax profit | -$6M | $11.2B | -$2.2B | $1.9B |
| Free Cash FlowCash after capex | $13M | $7.1B | $2.3B | $2.5B |
| Gross MarginGross profit ÷ Revenue | +56.6% | +37.2% | +38.2% | +33.1% |
| Operating MarginEBIT ÷ Revenue | -10.2% | +15.5% | +4.5% | +19.0% |
| Net MarginNet income ÷ Revenue | -9.0% | +11.5% | -5.8% | +11.4% |
| FCF MarginFCF ÷ Revenue | +18.1% | +7.3% | +6.2% | +15.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +35.8% | +6.5% | -0.8% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -31.2% | -29.8% | -5.5% | -35.8% |
Valuation Metrics
FOXA leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 12.8x trailing earnings, FOXA trades at a 86% valuation discount to WBD's 93.5x P/E. On an enterprise value basis, FOXA's 4.5x EV/EBITDA is more attractive than CURI's 23.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $181M | $187.5B | $68.0B | $14.1B |
| Enterprise ValueMkt cap + debt − cash | $175M | $226.7B | $96.0B | $16.2B |
| Trailing P/EPrice ÷ TTM EPS | -28.00x | 15.76x | 93.48x | 12.82x |
| Forward P/EPrice ÷ next-FY EPS est. | 88.00x | 15.97x | — | 13.56x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.52x |
| EV / EBITDAEnterprise value multiple | 23.74x | 11.83x | 13.72x | 4.49x |
| Price / SalesMarket cap ÷ Revenue | 2.52x | 1.99x | 1.82x | 0.86x |
| Price / BookPrice ÷ Book value/share | 4.28x | 1.71x | 1.85x | 2.35x |
| Price / FCFMarket cap ÷ FCF | 13.96x | 18.61x | 22.01x | 4.71x |
Profitability & Efficiency
FOXA leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
FOXA delivers a 17.0% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-13 for CURI. CURI carries lower financial leverage with a 0.30x debt-to-equity ratio, signaling a more conservative balance sheet compared to WBD's 0.88x. On the Piotroski fundamental quality scale (0–9), DIS scores 8/9 vs CURI's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -13.1% | +9.8% | -5.9% | +17.0% |
| ROA (TTM)Return on assets | -8.2% | +5.6% | -2.2% | +8.8% |
| ROICReturn on invested capital | -12.2% | +6.9% | +1.5% | +16.5% |
| ROCEReturn on capital employed | -13.6% | +8.5% | +1.5% | +16.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 8 | 6 | 8 |
| Debt / EquityFinancial leverage | 0.30x | 0.39x | 0.88x | 0.60x |
| Net DebtTotal debt minus cash | -$6M | $39.2B | $28.0B | $2.1B |
| Cash & Equiv.Liquid assets | $18M | $5.7B | $4.6B | $5.4B |
| Total DebtShort + long-term debt | $12M | $44.9B | $32.6B | $7.5B |
| Interest CoverageEBIT ÷ Interest expense | — | 9.95x | 2.00x | 7.74x |
Total Returns (Dividends Reinvested)
Evenly matched — CURI and FOXA each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FOXA five years ago would be worth $16,879 today (with dividends reinvested), compared to $3,124 for CURI. Over the past 12 months, WBD leads with a +200.9% total return vs CURI's -21.7%. The 3-year compound annual growth rate (CAGR) favors CURI at 53.9% vs DIS's 2.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -16.0% | -3.5% | -4.9% | -14.3% |
| 1-Year ReturnPast 12 months | -21.7% | +3.9% | +200.9% | +25.9% |
| 3-Year ReturnCumulative with dividends | +264.4% | +7.3% | +101.4% | +100.7% |
| 5-Year ReturnCumulative with dividends | -68.8% | -40.1% | -27.2% | +68.8% |
| 10-Year ReturnCumulative with dividends | -63.9% | +11.1% | -3.7% | +31.1% |
| CAGR (3Y)Annualised 3-year return | +53.9% | +2.4% | +26.3% | +26.1% |
Risk & Volatility
Evenly matched — WBD and FOXA each lead in 1 of 2 comparable metrics.
Risk & Volatility
FOXA is the less volatile stock with a 0.54 beta — it tends to amplify market swings less than CURI's 1.30 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WBD currently trades 90.4% from its 52-week high vs CURI's 43.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.30x | 0.91x | 0.87x | 0.54x |
| 52-Week HighHighest price in past year | $7.15 | $124.69 | $30.00 | $76.39 |
| 52-Week LowLowest price in past year | $2.81 | $92.19 | $8.06 | $50.03 |
| % of 52W HighCurrent price vs 52-week peak | +43.1% | +86.6% | +90.4% | +82.4% |
| RSI (14)Momentum oscillator 0–100 | 45.8 | 65.7 | 46.6 | 51.9 |
| Avg Volume (50D)Average daily shares traded | 350K | 9.0M | 22.0M | 3.3M |
Analyst Outlook
Evenly matched — CURI and FOXA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CURI as "Buy", DIS as "Buy", WBD as "Hold", FOXA as "Hold". Consensus price targets imply 28.2% upside for DIS (target: $138) vs 10.9% for WBD (target: $30). For income investors, CURI offers the higher dividend yield at 12.39% vs DIS's 0.92%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $3.67 | $138.44 | $30.06 | $70.17 |
| # AnalystsCovering analysts | 9 | 63 | 32 | 48 |
| Dividend YieldAnnual dividend ÷ price | +12.4% | +0.9% | — | +1.0% |
| Dividend StreakConsecutive years of raises | 2 | 1 | 1 | 3 |
| Dividend / ShareAnnual DPS | $0.38 | $1.00 | — | $0.60 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.9% | 0.0% | +7.1% |
FOXA leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). CURI leads in 1 (Income & Cash Flow). 3 tied.
CURI vs DIS vs WBD vs FOXA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CURI or DIS or WBD or FOXA a better buy right now?
For growth investors, CuriosityStream Inc.
(CURI) is the stronger pick with 40. 1% revenue growth year-over-year, versus -5. 1% for Warner Bros. Discovery, Inc. (WBD). Fox Corporation (FOXA) offers the better valuation at 12. 8x trailing P/E (13. 6x forward), making it the more compelling value choice. Analysts rate CuriosityStream Inc. (CURI) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CURI or DIS or WBD or FOXA?
On trailing P/E, Fox Corporation (FOXA) is the cheapest at 12.
8x versus Warner Bros. Discovery, Inc. at 93. 5x. On forward P/E, Fox Corporation is actually cheaper at 13. 6x.
03Which is the better long-term investment — CURI or DIS or WBD or FOXA?
Over the past 5 years, Fox Corporation (FOXA) delivered a total return of +68.
8%, compared to -68. 8% for CuriosityStream Inc. (CURI). Over 10 years, the gap is even starker: FOXA returned +31. 1% versus CURI's -63. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CURI or DIS or WBD or FOXA?
By beta (market sensitivity over 5 years), Fox Corporation (FOXA) is the lower-risk stock at 0.
54β versus CuriosityStream Inc. 's 1. 30β — meaning CURI is approximately 142% more volatile than FOXA relative to the S&P 500. On balance sheet safety, CuriosityStream Inc. (CURI) carries a lower debt/equity ratio of 30% versus 88% for Warner Bros. Discovery, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CURI or DIS or WBD or FOXA?
By revenue growth (latest reported year), CuriosityStream Inc.
(CURI) is pulling ahead at 40. 1% versus -5. 1% for Warner Bros. Discovery, Inc. (WBD). On earnings-per-share growth, the picture is similar: The Walt Disney Company grew EPS 151. 8% year-over-year, compared to 54. 2% for CuriosityStream Inc.. Over a 3-year CAGR, FOXA leads at 5. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CURI or DIS or WBD or FOXA?
Fox Corporation (FOXA) is the more profitable company, earning 13.
9% net margin versus -9. 0% for CuriosityStream Inc. — meaning it keeps 13. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FOXA leads at 19. 8% versus -10. 2% for CURI. At the gross margin level — before operating expenses — CURI leads at 56. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CURI or DIS or WBD or FOXA more undervalued right now?
On forward earnings alone, Fox Corporation (FOXA) trades at 13.
6x forward P/E versus 88. 0x for CuriosityStream Inc. — 74. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DIS: 28. 2% to $138. 44.
08Which pays a better dividend — CURI or DIS or WBD or FOXA?
In this comparison, CURI (12.
4% yield), FOXA (1. 0% yield), DIS (0. 9% yield) pay a dividend. WBD does not pay a meaningful dividend and should not be held primarily for income.
09Is CURI or DIS or WBD or FOXA better for a retirement portfolio?
For long-horizon retirement investors, Fox Corporation (FOXA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
54), 1. 0% yield). Both have compounded well over 10 years (FOXA: +31. 1%, WBD: -3. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CURI and DIS and WBD and FOXA?
Both stocks operate in the Communication Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CURI is a small-cap high-growth stock; DIS is a mid-cap deep-value stock; WBD is a mid-cap quality compounder stock; FOXA is a mid-cap high-growth stock. CURI, DIS, FOXA pay a dividend while WBD does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 17%
- Gross Margin > 33%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.